血清和尿CN1在老年糖尿病肾病中的诊断价值分析

doi:10.3969/j.issn.1003-9198.2023.08.019

摘要/Abstract

摘要： 目的研究血清和尿中肌肽二肽酶1(CN1)对老年糖尿病肾病(DN)的诊断价值。方法选取我院诊治的168例T2DM病人,根据尿白蛋白/肌酐比值(UACR),分为对照组(UACR＜30 mg/g,n=46)和DN组(UACR≥30 mg/g,n=122)。比较2组血清和尿中CN1水平及临床生化指标,并进行相关性分析。采用多因素Logistic回归分析影响DN发生的因素。采用ROC曲线分析各指标对DN的诊断价值。结果与对照组比较,DN组估计肾小球滤过率(eGFR)较低,而UACR、血肌酐、血BUN、血UA、胱抑素C、血清和尿CN1水平明显较高,差异具有统计学意义(均P<0.05)。血清、尿CN1水平与UACR、血肌酐、血BUN水平呈显著正相关,与eGFR呈显著负相关(均P<0.05)。eGFR、胱抑素C、血清CN1和尿CN1是DN的独立影响因素。ROC曲线分析显示,eGFR、胱抑素C、血清CN1、尿CN1及联合检测对DN诊断的AUC分别为0.851、0.760、0.838、0.849、0.944,联合检测的AUC显著优于单项指标(P<0.05)。结论 DKD病人血清和尿CN1水平升高,是影响老年T2DM病人DN发生的独立危险因素,eGFR、胱抑素C、血清和尿CN1联合检测对DN具有较高的诊断价值。

关键词: 老年人, 糖尿病肾脏病, 肌肽二肽酶1, 危险因素, 诊断价值

Abstract: Objective To study the clinical value of serum and urine carnosine dipeptidase 1 (CN1) in the diagnosis of diabetic nephropathy (DN) in the elderly. Methods A total of 168 elderly patients with type 2 diabetes mellitus (T2DM) in our hospital were enrolled and divided into control group (n=46) and DN group (n=122) according to whether the level of urinary albumin creatinine ratio (UACR) was≥30 mg/g. The serum and urine levels of CN1 and the serum levels of the clinical biochemical indicators were compared between the two groups, and were analyzed by Pearson correlation. Multivariate Logistic regression analysis was used to analyze the influencing factors of DN. The diagnostic value of each index for DN was analyzed by the receiver operating characteristic (ROC) curve. Results Compared with the control group, the level of estimated glomerular filtration rate (eGFR) was lower, while the UACR, the serum levels of creatinine, urea nitrogen, uric acid and cystatin C, and the serum and urine levels of CN1 were significantly higher in the DN group (all P<0.05). Serum and urine levels of CN1 were significantly positively correlated with UACR, serum levels of creatinine and urea nitrogen, and significantly negatively correlated with eGFR (all P<0.05). The levels of eGFR, cystatin C, serum and urine CN1 were the independent influencing factors of DN. The area under the ROC curve (AUC) of eGFR, cystatin C, serum CN1, urine CN1 and combined detection for the diagnosis of DN were 0.851, 0.760, 0.838, 0.849 and 0.944, respectively. The AUC of combined detection was significantly better than that of single indicator (P<0.05). Conclusions The increased serum and urinary levels of CN1 in diabetic patients are independent risk factors affecting the occurrence of DN in the elderly. Combined detection of eGFR, cystatin C, serum and urinary CN1 has high diagnostic value for DN.

Key words: aged, diabetic nephropathy, carnosine dipeptidase 1, risk factor, diagnostic value

中图分类号:

R 587.2

贺晔楠, 孙明霞, 宋丹丹, 赵晓兰. 血清和尿CN1在老年糖尿病肾病中的诊断价值分析[J]. 实用老年医学, 2023, 37(8): 834-838.

HE Ye-nan, SUN Ming-xia, SONG Dan-dan, ZHAO Xiao-lan. Diagnostic value of serum and urine CN1 for diabetic nephropathy in elderly patients[J]. Practical Geriatrics, 2023, 37(8): 834-838.

参考文献

[1] LOVIC D, PIPERIDOU A, ZOGRAFOU I, et al. The growing epidemic of diabetes mellitus[J]. Curr Vasc Pharmacol, 2020, 18(2):104-109.
[2] BONNER R, ALBAJRAMI O, HUDSPETH J, et al. Diabetic kidney disease[J]. Prim Care, 2020, 47(4):645-659.
[3] 中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏疾病防治临床指南[J]. 中华糖尿病杂志, 2019, 11(1):15-28.
[4] YADAV A K, SINHA N, KUMAR V, et al. Association of CTG repeat polymorphism in carnosine dipeptidase 1 (CNDP1) gene with diabetic nephropathy in north Indians[J]. Indian J Med Res, 2016, 144(1):32-37.
[5] ZHANG S, XU J, CUI D, et al. Genotype distribution of polymorphisms in the healthy Chinese Han population: association with HbA1c and fasting blood glucose[J]. J Diabetes Res, 2020, 18(6):3838-3845.
[6] RODRIGUEZ-NIÑO A, HAUSKE S J, HEROLD A, et al. Serum carnosinase-1 and albuminuria rather than the genotype correlate with urinary carnosinase-1 in diabetic and nondiabetic patients with chronic kidney disease[J]. J Diabetes Res, 2019, 20(19):6850-6858.
[7] SANTOS K G. The (CTG) repeat polymorphism in gene: new insights into an old molecule[J]. Indian J Med Res, 2016, 144(1):6-8.
[8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1):4-67.
[9] FILIPPATOS G, ANKER S D, AGARWAL R, et al. Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes[J]. Circulation, 2021, 143(6):540-552.
[10] SCHMÖHL F, PETERS V, SCHMITT C P, et al. CNDP1 knockout in zebrafish alters the amino acid metabolism, restrains weight gain, but does not protect from diabetic complications[J]. Cell Mol Life Sci, 2019, 76(22):4551-4568.
[11] RIEDL E, KOEPPEL H, PFISTER F, et al. N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia[J]. Diabetes, 2010, 59(8):1984-1990.
[12] EVERAERT I, HE J, HANSSENS M, et al. Carnosinase-1 overexpression, but not aerobic exercise training, affects the development of diabetic nephropathy in BTBR mice[J]. Am J Physiol Renal Physiol, 2020, 318(4):1030-1040.
[13] 何鑫, 杨文强, 李宗泽, 等. 肌肽对糖尿病肾病大鼠氧化应激及NF-κB信号通路的影响[J]. 中国临床解剖学杂志, 2020, 38(3):289-294.
[14] GHODSI R, KHEIROURI S. Carnosine and advanced glycation end products: a systematic review[J]. Amino Acids, 2018, 50(9):1177-1186.
[15] QIU J, HAUSKE S J, ZHANG S, et al. Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity[J]. Amino Acids, 2019, 51(1):7-16.
[16] QIU J, ALBRECHT T, ZHANG S, et al. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR mice[J]. J Mol Med: Berl, 2020, 98(9):1333-1346.
[17] RODRIGUEZ-NIÑO A, PASTENE D O, HETTLER S A, et al. Influence of carnosine and carnosinase-1 on diabetes-induced afferent arteriole vasodilation: implications for glomerular hemodynamics[J]. Am J Physiol Renal Physiol, 2022, 323(1):F69-F80.
[18] WEIGAND T, COLBATZKY F, PFEFFER T, et al. A global cndp1-knock-out selectively increases renal carnosine and anserine concentrations in an age- and gender-specific manner in mice[J]. Int J Mol Sci, 2020, 21(14):4887-4893.
[19] 王丽之, 黄若妃, 吕美艳, 等.老年糖尿病肾病患者血清糖化血红蛋白、IL-6、胱抑素C与肾小球滤过率的相关性分析[J]. 中华全科医学, 2022, 20(6):1019-1021, 1055.